A look at where tech developments are originating and what to expect.
Procedures for design validation must address risk analysis where appropriate.
MRI-compatible pacemakers are among the technologies gaining traction.
Validation is an obstacle to implementing technology. A streamlined approach is necessary.
With the heightened supplier scrutiny, it’s time to reevaluate your supplier quality program.
Technology isn’t the only driver in this change; the sociological factor plays a role as well.
When it comes to adverse event reporting, the FDA does not grant exemptions.
Many considerations should not be overlooked.
Digital transformation, artificial intelligence and start-up technologies are some of the topics that will be discussed at the event in November.
After one year into the transition period, it is clear that manufacturers are not where they need to be in meeting the compliance deadline.